Stock Alert: Curis Soars 400% On Positive Leukemia Trial Results

By RTTNews Staff Writer   ✉   | Published:

Shares of Curis, Inc. (CRIS) skyrocketed more than five-fold on Tuesday morning after the biotechnology company focused on cancer treatment reported positive leukemia treatment trial results.

CRIS is currently trading at $7.28, up $5.84 or 405.75%, on the Nasdaq.

Curis announces positive preliminary data from ongoing phase 1 study of CA-4948 monotherapy in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes.

Curis said reduction of marrow blasts observed in all evaluable patients and marrow complete response observed in 2 patients.

"We are highly encouraged by the breadth of clinical activity with CA-4948 seen with this early data, especially as this study is both monotherapy and in a late line, relapsed/refractory population. Historically, monotherapy studies in AML and MDS have proven underwhelming; monotherapy studies in a relapsed/refractory setting have been especially challenging," said James Dentzer, President and Chief Executive Officer of Curis.

For comments and feedback contact: editorial@rttnews.com

Business News

Previous Story
Next Story
Editors Pick
Restaurants Closures And Bankruptcies Continue To Rise
There has been continued business deterioration across the restaurant industry, with restaurant closures and bankruptcies continuing to rise across the U.S. and job losses growing at some of the prominent restaurants, according to a new survey by the National Restaurant Association or NRA. The survey details were shared by the NRA in a letter to the Congressional leadership.
Dish Network To Pay $210 Mln In Penalties To Settle Telemarketing Violations Suit
DISH Network LLC, a unit of Dish Network Corp., has agreed with the Department of Justice and four states to pay $210 million in penalties to settle telemarketing violations suit. In a statement, the Justice Department said the direct-broadcast satellite provider will pay $126 million in civil penalties to the United States. The company allegedly placed millions of telemarketing calls.
Canada In Deal With Pfizer For Covid-19 Vaccine As UK Begins Vaccination
Canada has secured an agreement with Pfizer to begin early delivery of doses of Pfizer-BioNTech's COVID-19 vaccine, Canadian Prime Minister Justin Trudeau revealed in a tweet. The news comes as UK became the first Western country to start mass vaccination against Covid-19 with the Pfizer vaccine today.